FDA approves Bexsero for use in 10- to 25-year-olds
Zaynab ZamanThe Food and Drug Administration recently approved Novartis’ meningitis B vaccine, Bexsero, which had been used to vaccinate University students. The vaccine is now approved for use in 10- to 25-year-olds in an effort to prevent the disease from spreading. Seven students and one visitor were diagnosed with and survivedmeningitis B in 2013.